title: Evaluation and treatment of pump thrombosis and hemolysis.
abstract: Ventricular assist devices (VADs) are not fully biocompatible, and are therefore predisposed to device thrombosis and subsequent pump dysfunction. Clinically significant hemolysis in VADs most often occurs as a result of device thrombosis, but can also be caused by other factors. Herein we describe the evaluation and management of VAD thrombosis and hemolysis.
authors.affiliation: 1 Division of Cardiothoracic Surgery, 2 Department of Cardiology, University of Rochester Medical Center, Rochester, NY 14642, USA.
authors.forename: Vakhtang
authors.initials: V
authors.lastname: Tchantchaleishvili
authors.affiliation: 1 Division of Cardiothoracic Surgery, 2 Department of Cardiology, University of Rochester Medical Center, Rochester, NY 14642, USA.
authors.forename: Fabio
authors.initials: F
authors.lastname: Sagebin
authors.affiliation: 1 Division of Cardiothoracic Surgery, 2 Department of Cardiology, University of Rochester Medical Center, Rochester, NY 14642, USA.
authors.forename: Ronald E
authors.initials: RE
authors.lastname: Ross
authors.affiliation: 1 Division of Cardiothoracic Surgery, 2 Department of Cardiology, University of Rochester Medical Center, Rochester, NY 14642, USA.
authors.forename: William
authors.initials: W
authors.lastname: Hallinan
authors.affiliation: 1 Division of Cardiothoracic Surgery, 2 Department of Cardiology, University of Rochester Medical Center, Rochester, NY 14642, USA.
authors.forename: Karl Q
authors.initials: KQ
authors.lastname: Schwarz
authors.affiliation: 1 Division of Cardiothoracic Surgery, 2 Department of Cardiology, University of Rochester Medical Center, Rochester, NY 14642, USA.
authors.forename: H Todd
authors.initials: HT
authors.lastname: Massey
keywords: Ventricular assist device (VAD); hemolysis; thrombosis